Chrysalis Intimacy Formulas With CBD

Chrysalis Intimacy Formulas With CBD

Oct 26th 2019

Improving Sexual Performance and Health!

CHRYSALIS INTIMACY CAPSULES FOR MALE AND FEMALE

Chrysalis™ Intimacy Capsules have been developed to help relieve or resolve the unfortunate issues that occur with sexual dysfunction, and if no dysfunction was present, Chrysalis Intimacy Capsules were formulated to enhance the sexual pleasure and experience of individuals or couples. Normal sexual function for each individual is a very complex interaction that is both psychological and physiological. The nervous, circulatory, and hormonal systems all interact with the mind to produce a physical outcome (preferably one that is pleasing) and a delicate and balanced interplay among these systems control the male and female sexual response. A sexual problem, or dysfunction, can occur during any phase of a sexual response cycle that prevents an individual (or couple) from experiencing satisfaction from sexual activity. The cycle has four phases: excitement, plateau, orgasm, and resolution. Sexual dysfunction is far more common than most people realize. It is most often the result of a physical or psychological condition and on average, 31% of men and 43% of women report some measurable degree of difficulty when it comes to sexual intercourse. Additionally, sexual dysfunction can be present in adults of varied ages. However, those most commonly affected are the older demographic categories, which may be related to a decline in health associated with aging.

  • PHYSICAL CAUSES
  • Conditions include diabetes, heart and vascular disease, neurological disorders, hormonal imbalances, chronic diseases such as kidney or liver failure, alcoholism and drug abuse, side effects of certain medications, some antidepressant drugs.
  • PSYCHOLOGICAL CAUSES

Conditions include work-related stress and anxiety, concern about sexual performance, marital or relationship problems, depression, feelings of guilt, and effects of a past sexual trauma.

Human sexual function is essential to life, both in propagation of the species as well as quality of life. Sexual dysfunction can lead to reduced quality of life and potentially reduction in procreation. Male sexual dysfunction (MSD), especially erectile problems, have been extensively studied and therapies are available for men with this disorder. However, female sexual dysfunction (FSD) is more complicated and significantly less understood in comparison to male sexual dysfunction.

Additionally, data has shown that use of THC over time can have a detrimental effect on male and female libido, causing lethargy and a general apathy towards sexual interaction thus exacerbating a sexual dysfunction condition that might be present. Comparatively, utilization of CBD has an inverse effect on both male and female libido, increasing sexual desire and greatly enhancing sexual intercourse, especially when paired with natural aphrodisiacs and Chrysalis™ SMS CBD that has been formulated through single molecule separation.

MALE SEXUAL DYSFUNCTION

Erectile dysfunction (ED) is the inability to achieve or maintain an erection sufficient for satisfactory sexual performance. It is common, affecting at least 12 million U.S. men. The condition can be caused by vascular, neurologic, psychological, and hormonal factors. Common conditions related to ED include diabetes mellitus, hypertension, hyperlipidemia, obesity, testosterone deficiency, and prostate cancer treatment. Performance anxiety and relationship issues are common psychological causes. Medications and substance use can cause or exacerbate ED; antidepressants and tobacco use are the most common. ED is associated with an increased risk of cardiovascular disease, particularly in men with metabolic syndrome. Tobacco cessation, regular exercise, weight loss, and improved control of diabetes, hypertension, and hyperlipidemia are recommended initial lifestyle interventions.

Many medications cause or exacerbate ED. Antidepressants are a common cause, especially the selective serotonin reuptake inhibitors citalopram (Celexa), fluoxetine (Prozac), paroxetine (Paxil), and sertraline (Zoloft), and the serotonin-norepinephrine reuptake inhibitor venlafaxine. Bupropion (Wellbutrin), mirtazapine (Remeron), and fluvoxamine are less likely to cause ED. Tobacco, alcohol, and illicit drugs can cause ED. Marijuana use may actually cause ED, although further study is needed. Low serum testosterone levels are one factor that may explain the relationship between metabolic syndrome and ED. The adipose tissue enzyme aromatase prevalent in obese men converts testosterone into estradiol, a significant cause of hypogonadism. Additionally, tobacco cessation is highly recommended. Compared with men who have never smoked, the risk of ED is increased by 51% in current smokers and 20% for ex-smokers.

FEMALE SEXUAL DYSFUNCTION

FEMALE SEXUAL INTENSITY CHARACTERISTICS

Female sexual function results from a complex neurovascular process that is controlled by psychological and hormonal inputs. Like any coordinated physiological response, multiple systems are involved in this function. In respect to proper vaginal and clitoral function, a sufficient blood supply is required for a satisfying sexual experience. The above figure (left) demonstrates relative pressure and volume values from the vagina and labia as well as the clitoris, during a period of arousal, orgasm and post-orgasm. Vaginal and labial data were derived from partial oxygen pressures detected at each tissue site while magnetic resonance imaging of the clitoris measured changes in volume during neutral and stimulating visual imagery. It represents a typical sexual response in women, however, the complexity and unique individual response allows for numerous sites of dysregulation, which can lead to Female Sexual Dysfunction (FSD). FSD is more complex and difficult to categorize due to a woman’s perception about sex when compared to males. FSD is a multifaceted disorder, comprising anatomical, psychological, physiological, as well as social-interpersonal components. With several existing FSD definitions, the most descriptive encompasses FSD as the persistent/recurring decrease in sexual desire or arousal, the difficulty/inability to achieve an orgasm, and/or the feeling of pain during sexual intercourse. Additionally, decreases in estrogen can play a role in female sexual function, and alterations in estradiol levels can result in vaginal wall smooth muscle atrophy and increased vaginal canal acidity, leading to discomfort and stress.

The data above also demonstrates psychogenic and hemodynamic events of the normal female sexual cycle, psychosexual responses from arousal, orgasm and post orgasm frame, approximate vaginal and labial pressures as well as clitoral volume. Increasing arousal that culminates in orgasm demonstrates increases in vaginal and labial pressures and filling of the clitoris. Concurrently, it shows changes in force (contraction and relaxation) of female internal pudendal artery stimulation. The internal pudendal artery supplies blood to the clitoris and labia minora of the vagina. Relaxation of the internal pudendal artery is essential to achieve tumescence during sexual stimulation. A compromised state of relaxation in this artery may play a role in female sexual dysfunction. Increasing blood delivery to the genitals with the development of the first marked PDE5 inhibitor, sildenafil revolutionized the treatment of erectile dysfunction in men. The physiological mechanism responsible for relaxation of smooth muscle of cavernous tissue (both male and female) is initiated with the release of nitric oxide (NO) from adjacent nerve endings and/or endothelial cells upon mental and sensory stimuli via spinal reflex.

TIMED SEXUAL RESPONSE CYCLE FOR FORMULATION OF CHRYSALIS INTIMACY CAPSULES

PHASE 1 – DESIRE: Characteristics of this phase, which can last from a few minutes to several hours, include the following:

  • Muscle tension increases.
  • Heart rate quickens and breathing is accelerated.
  • Skin may become flushed (blotches of redness appear on the chest and back).
  • Nipples become hardened or erect.
  • Blood flow to the genitals increases, resulting in swelling of the woman’s clitoris and labia minora (inner lips), and erection of the man’s penis.
  • Vaginal lubrication begins.
  • The woman’s breasts become fuller and the vaginal walls begin to swell.
  • The man’s testicles swell, his scrotum tightens, and he begins secreting a lubricating liquid.

PHASE 2 – AROUSAL: General characteristics of this phase, which extends to the brink of orgasm, include the following:

  • The changes begun in phase 1 are intensified.
  • The vagina continues to swell from increased blood flow, and the vaginal walls turn a dark purple.
  • The woman’s clitoris becomes highly sensitive (may even be painful to touch) and retracts under the clitoral hood to avoid direct stimulation from the penis.
  • The man’s testicles are withdrawn up into the scrotum.
  • Breathing, heart rate and blood pressure continue to increase.
  • Muscle spasms may begin in the feet, face and hands.
  • Tension in the muscles increases.

PHASE 3 – ORGASM: This phase is the climax of the sexual response cycle. It is the shortest of the phases and may last only a few seconds. General characteristics of this phase include the following:

  • Involuntary muscle contractions begin.
  • Blood pressure, heart rate and breathing are at their highest rates, with a rapid intake of oxygen.
  • Muscles in the feet spasm.
  • There is a sudden, forceful release of sexual tension.
  • In women, the muscles of the vagina contract. The uterus also undergoes rhythmic contractions.
  • In men, rhythmic contractions of the muscles at the base of the penis result in the ejaculation of semen.
  • A rash or "sex flush" may appear over the entire body.

PHASE 4 – RESOLUTION: During this phase, the body slowly returns to its normal level of functioning and swelled and erect body parts return to their previous size and color. This phase is marked by a general sense of well-being and, often, fatigue. Some women are capable of a rapid return to the orgasm phase with further sexual stimulation and may experience multiple orgasms. Men need recovery time after orgasm, called a refractory period, during which they cannot reach orgasm again. The duration of the refractory period varies among men and changes with age.

CHRYSALIS™ INTIMACY CAPSULES FORMULATION

The demand for prescription pharmaceuticals to treat sexual dysfunction (both male and female) is projected to reach $10BN USD by 2026 and all of these drugs are created by synthetic means.

Potential side effects and cost are of particular concern for most. There are many who would prefer a completely natural, non-prescription, effective solution for assisting with a multitude of sexual dysfunction issues, especially if the solution had been formulaically targeted to assist and improve specific issues for males and females as shown below:

MALE TARGET BENEFITSFEMALE TARGET BENEFITS
Increased DesireIncreased Desire
Faster ArousalFaster Arousal
Increased Penile Blood FlowIncreased Clitoral and Labial Blood Flow
Ease of Erection InitiationHeightened Sensitivity
Erection LongevityIncreased Lubrication
Greater StaminaGreater Orgasm Intensity
Shorter Refractory PeriodGreater Orgasm Frequency
Heightened PleasureHeightened Pleasure
Increased Testosterone ProductionIncreased Long Term Libido

CHRYSALIS™ INTIMACY CAPSULES ARE SPECIFICALLY FORMULATED FOR THE DIFFERENT NEEDS OF MALES AND FEMALES

Males and females have different arousal states and unfortunately, at this time there is no single chemical that has been found to be able to initiate a female arousal response within a specified period of time, such as Viagra or Cialis for men does for many men. It was for this reason specific paired molecules within BOTH male and female Chrysalis™ Intimacy Capsules formulas were critical in precisely timing out a tandem arousal responses.

INTIMACY CAPSULE FORMULA INGREDIENTS WERE SELECTED TO DELIVER MORE

In addition to addressing the above needs for men and women, Chrysalis CBD has been specifically-paired with several all-natural ingredients selected to increase individual dopamine response, production of serotonin, produce heightened levels of pheromones, and initiate specifically timed results within couple’s interaction. Chrysalis™ Intimacy Capsule additional benefits include:

  • Synced initiation of interest through initiation of L-Dopamine
  • Matched desire cycle through entourage effect of ingredients in each of the male and female formulas
  • Consistent pheromone production over a five-day period within the couple’s household
  • Increased hormonal levels of testosterone and estrogen
  • Increased testicular function raising sperm production
  • Increased vaginal and clitoral sensitivity
  • Increased blood flow and nitric oxide production in both male and female formulas
  • Three days of individual benefits from single use
  • Long term alleviation of ED and FSD issues with continued use

Chrysalis Intimacy Capsules have the ability to significantly improve sexual performance and can be an important addition to a program to improve the sexual health of men and women.

Products In This Article

JOIN OUR "FLUTTER" GROUP!

Get the latest updates on new products and upcoming sales

No thanks